Really pleased to see this work, looking at stability of the immune system after Long COVID, is published!
https://t.co/sdNRD6sUbb
I'll write an explanation of our findings (and further scientific context) soon!
@RobLawrencium I wonder how much is people using LLM to write their abstracts for them vs using LLM to tidy up their language vs inception of these words and phrases because people read more text written by LLMs
Have you heard our latest Session ? Dr Ben Krishna and the team at Cambridge University have identified a protein, elevated in the blood of #LongCovid patients. Available on all platforms, here is a link to one. @BenjaminKrishn3@Cambridge_Uni available on all platforms.
The journal were generous with revision extensions while I was on maternity leave, and @BenjaminKrishn3 did heroic extra experiments to get us over the line.
Can't find any evidence here that this is actually happening though?
Biochemistry has gone back to closed book exams now that COVID restrictions are over (ie for the last two years).
If @UniofOxford has decided to trash itself, it will deserve to crash down international league tables. But the dumbing down of education across the university sector is a disaster for the nation. The next gov’t should bring in a Royal Commission. https://t.co/stdH4DPGqT
At some point in the last ten years (it’s hard to tease out exactly when) we crossed a boundary that no one celebrated:
Most people diagnosed with cancer in the United States of America this year will not be killed by that cancer.
Yes, outcomes have improved.
@HarrietGroom Yeah I’m assuming the Telegraph are misrepresenting a recommendation in a report by one guy from one department. BMB is closed book exams entirely
I tried putting my biochemistry mock exam questions into ChatGPT. It does surprisingly well, but not brilliantly (high 2:2).
Right now the smoking gun is eloquent writing, vast information but poor knowledge synthesis. I’m sure it will cover that gap though
Can we also just reflect on the insanity of doing this at precisely the point when ChatGPT and other AI tools have made traditional closed book exams by far the most reliable assessment method
Our next KIER (Knowledge, Inclusion and Equity in Research) book club will be on the 28th February, where we'll be discussing Medical Apartheid, a book about the non-consensual use of African American people in medical research
You only get cake if you attend!
@mhornig I’ve been complaining for a few years now that Long COVID studies often have the wrong control groups (or poorly defined criteria). It’s sort of a topic close to my heart!
More of this please!
New from @BenjaminKrishn3, Nyarie Sithole w/relevance for #LongCOVID. Pertinent to 1st-wavers w/out timely access to appropriate diagnostics as well as those in the current don't-look-so-you-can't-find era.
There's a concept called the "Gentlemen's Third" where you get the lowest pass mark possible and spend your time making friends and having fun (essentially networking) which was much more useful in the long term
One odd thing you see in older British books is that, for their upper classes, college wasn't *that* important.
You were kind of supposed to go up to Oxford or Cambridge, but it wasn't very important if you actually graduated.
It was common/fine to leave after a few terms.
🚨 New article alert! 🚨
I wrote an article in @Nature about how anyone in a well-resourced lab can implement to democratise scientific resources and training worldwide. 🌍🧪
👉 https://t.co/3fvcoKoi61
@Cambridge_Uni@MedCambridge@CaiusCollege @MRC_LMB
This year @MedCambridge hosted 4 EPLS students in our labs. It was a really fun and valuable experience for everyone involved. Looking forward to doing it again next year!
This year’s Experience Postgrad Life Sciences summer internship programme has come to a close and what an amazing journey!
Thank you to all the talented participants for their hard work and enthusiasm!
3. Increased risk of CVD after COVID-19 could be considered a symptom of Long COVID. Whether clotting or microclots links to Long Covid isn't yet clear. Data from clinical trials targeting clots will be very informative on this issue.
https://t.co/7BpXn2HhnS
Review written by us in collaboration with Alejandro Salinas-Botrán and colleagues (none of whom seem to be on twitter) thinking about cardiovascular disease and COVID-19. Essentially... (1/4)
2. How long this risk lasts isn't totally clear, and epidemiological research on this is really useful. Patients who have severe COVID-19 should have follow up checks to mitigate the chances of adverse cardiovascular events later on.